##  [Successful Filing of LCM-Grouped Submissions for an IND](/index%2ephp/case-studies/successful-filing-of-lcm-grouped-submissions-for-an-ind) 

- [Medicinal Products](/index%2ephp/case-studies-main-categories/medicinal-products)
- [Publishing and Submission](/index%2ephp/case-studies-main-categories/publishing-and-submission)





[US FDA](/index%2ephp/case-studies-heath-authority/us-fda)

 

 ![Successful Filing of LCM-Grouped Submissions for an IND]()

A USA-based innovative pharmaceutical company was looking for Regulatory support in filing LCM-grouped submissions to the USFDA. The client’s project presented several challenges, such as:

- End-to-end publishing activities from study documents to the final ESG submission
- Filing of submissions under stringent timelines

Freyr’s team addressed the challenges by working under rigid timelines. The team offered extensive support by conducting a review of all the source documents and tracking each of the version changes made throughout the publishing cycle.

Decode how Freyr worked against time and achieved 100% success in filing the submissions whilst evaluating the time and cost constraints. Download the proven case.



Fill the form below to download the Case Study

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name